Macquarie upgrades its forecasts, based on GNC's update. Now forecasting:
FY2022
Revenue: $6.02b
EBITDA: $519m
NPAT: $268m ($1.19/share)
Dividend: 27cps
FY2023
Revenue: $4.75b
EBITDA: $295m
NPAT: $117m (53c/share)
Dividend: 26cps
Its valuation and 12-month target price is $9.48.
I think Macquarie's dividend forecasts are light given expected npat, but they might be expecting ongoing share buybacks (remember that a $50m buy back is to commence this month ...).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.91 |
Change
0.000(0.00%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $7.96 | $8.02 | $7.91 | $5.713M | 719.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4879 | $7.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.95 | 3117 | 1 |
View Market Depth
| Last trade - 16.12pm 26/06/2025 (20 minute delay) ? |
| GNC (ASX) Chart |